XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Stock award plan - (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2021

 

10,772,582

$

43.66

 

  

 

  

Granted

 

1,471,290

37.86

 

  

 

  

Exercised

 

(125,020)

25.59

 

  

 

  

Forfeited/Cancelled

 

(302,900)

49.52

 

  

 

  

Outstanding at June 30, 2022

 

11,815,952

$

42.98

 

6.79

years

$

52,784

Vested or Expected to vest at June 30, 2022

 

4,180,409

$

47.70

 

8.42

years

$

6,220

Exercisable at June 30, 2022

 

7,208,199

$

39.96

 

5.72

years

$

45,995

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Six months ended

    

June 30, 2022

Risk-free interest rate

 

1.55% - 3.07%

Expected volatility

 

55.33% - 73.56%

Expected term

 

5.5 years

Summary of information on the Company's restricted stock

Restricted Stock Awards and Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2021

1,519,831

$

55.43

Granted

 

1,580,362

38.03

Vested

 

(476,223)

50.44

Forfeited

 

(109,143)

47.85

Unvested at June 30, 2022

 

2,514,827

$

45.74

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2022

    

2021

    

2022

    

2021

Research and development

$

13,798

$

13,443

$

26,832

$

27,168

Selling, general and administrative

 

13,932

 

12,256

 

27,487

 

24,238

Total

$

27,730

$

25,699

$

54,319

$

51,406